<code id='5FCF477EAC'></code><style id='5FCF477EAC'></style>
    • <acronym id='5FCF477EAC'></acronym>
      <center id='5FCF477EAC'><center id='5FCF477EAC'><tfoot id='5FCF477EAC'></tfoot></center><abbr id='5FCF477EAC'><dir id='5FCF477EAC'><tfoot id='5FCF477EAC'></tfoot><noframes id='5FCF477EAC'>

    • <optgroup id='5FCF477EAC'><strike id='5FCF477EAC'><sup id='5FCF477EAC'></sup></strike><code id='5FCF477EAC'></code></optgroup>
        1. <b id='5FCF477EAC'><label id='5FCF477EAC'><select id='5FCF477EAC'><dt id='5FCF477EAC'><span id='5FCF477EAC'></span></dt></select></label></b><u id='5FCF477EAC'></u>
          <i id='5FCF477EAC'><strike id='5FCF477EAC'><tt id='5FCF477EAC'><pre id='5FCF477EAC'></pre></tt></strike></i>

          leisure time

          leisure time

          author:entertainment    Page View:6
          Eric Lander White House science office
          Eric Lander resigned as President Biden’s science adviser, after a White House investigation found “credible evidence” that he had violated workplace conduct rules. Photo illustration: Alex Hogan/STAT; Source: Getty

          WASHINGTON — An early sign that trouble was afoot in the White House science office came last November, when roughly a dozen of Eric Lander’s staff formed a “culture committee” aimed at improving morale.

          The group’s first action, five aides told STAT, was to create a “word cloud” depicting the adjectives they most often used to describe the work environment at the White House Office of Science and Technology Policy. Of the dozens of words submitted, three in particular stood out: “hostile,” “siloed,” and “aggressive.”

          advertisement

          Three months later, Lander resigned as President Biden’s science adviser, after Politico reported a White House investigation that found “credible evidence” that he had violated workplace conduct rules.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Amylyx ALS drug fails large clinical trial
          Amylyx ALS drug fails large clinical trial

          JustinKlee(left)andJoshuaCohenaretheco-foundersandco-CEOsofAmylyxPharmaceuticals.KayanaSzymczakforST

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          RSV shot was 90% effective at preventing hospitalizations in kids

          Thiselectronmicroscopeimageshowshumanrespiratorysyncytialvirus(RSV)virions,colorizedblue,andanti-RSV